98 results on '"Isophane Insulin, Human"'
Search Results
2. RCT Glargine vs NPH for Treatment of DM in Pregnancy
3. Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
4. The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
5. Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes (PREDICTIVE™)
6. DETERMINE: Detemir vs NPH (DETERMINE)
7. Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes (3L)
8. Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
9. Detemir Energy Expenditure Study (DEES)
10. Comparison of Insulin Therapy in Treating Post-Transplant Diabetes
11. A 'Real World' Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to 'Standard of Care' Basal Insulin in Patients Already Using Basal Insulin (REGAIN CONTROL)
12. A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
13. A 'Real World' Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to 'Standard of Care' Basal Insulins in Insulin Naïve Patients Initiating Insulin (Reach-Control)
14. Insulin Schemes for Type 2 Diabetes Control
15. Toujeo Versus NPH Self-titration Study
16. Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
17. Comparison of Two Biphasic Insulin Regimens
18. Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
19. Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
20. Comparison Study of Insulin Glargine and NPH Insulin
21. Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N
22. Treatment of Latent Autoimmune Diabetes of the Adult (LADA)
23. Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients (ITP-NODAT)
24. Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women
25. A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin (iDEAt2)
26. Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)
27. Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia
28. A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes (IMAGINE 6)
29. Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
30. Glargine Versus NPH in Patients With Chronic Kidney Disease
31. Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus
32. Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy (ktpump)
33. Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
34. Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (MIPOD)
35. Insulin Glargine at Bedtime or in AM Versus NPH
36. Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
37. NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
38. Safety of Insulin Detemir in Children With Type 1 Diabetes
39. Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
40. Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes
41. Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
42. Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
43. Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
44. Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
45. Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
46. The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients (GIH)
47. Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
48. Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
49. Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
50. Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard® (EVIDENCE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.